62.60

1.54% 0.95

Pre-market: 61.99 -0.61 -0.97%

Genedx Holdings Corp (WGS)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Genedx Holdings Corp stock is traded at $62.60, with a volume of 723.37K. It is up +1.54% in the last 24 hours and up +12.96% over the past month. GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Previous Close:

$61.65

Open:

$61.5

24h Volume:

723.37K

Relative Volume:

0.57

Market Cap:

$1.86B

Revenue:

$442.68M

Net Income/Loss:

$-77.81M

P/E Ratio:

-23.46

EPS:

-2.6684

Net Cash Flow:

$-28.65M

1W Performance:

-5.35%

1M Performance:

+12.96%

6M Performance:

-38.56%

1Y Performance:

-22.62%

1-Day Range:

$60.34

$62.79

1-Week Range:

$58.14

$67.44

52-Week Range:

$32.21

$170.87

Genedx Holdings Corp Stock (WGS) Company Profile

Name

Genedx Holdings Corp

Sector

Healthcare (1073)

Industry

Diagnostics & Research (50)

Phone

888-729-1206

Address

333 LUDLOW STREET, STAMFORD

Employee

1,300

Twitter

Next Earnings Date

2026-08-03

Latest SEC Filings

WGS's Discussions on Twitter

Compare WGS vs TMO, DHR, IDXX, NTRA, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WGS Genedx Holdings Corp	62.60	1.86B	442.68M	-77.81M	-28.65M	-2.6684
TMO Thermo Fisher Scientific Inc	526.46	195.64B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	179.14	125.93B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	545.00	42.99B	4.45B	1.10B	1.06B	13.59
NTRA Natera Inc	264.22	37.84B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	133.46	37.69B	7.23B	1.41B	1.09B	4.979

Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-26	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-20-25	Initiated	Canaccord Genuity	Buy
Jul-09-25	Initiated	Piper Sandler	Overweight
May-15-25	Initiated	Guggenheim	Buy
May-09-25	Upgrade	Jefferies	Hold → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jul-10-24	Initiated	Craig Hallum	Buy
Jun-03-24	Resumed	Jefferies	Hold

View All

Genedx Holdings Corp Stock (WGS) Latest News

01:48 AM

Trading the Move, Not the Narrative: (WGS) Edition - Stock Traders Daily

01:48 AM

Jul 22, 2026

WGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- August 3, 2026 Deadline - PR Newswire

Jul 22, 2026

WGS Deadline: WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - Charleston Gazette-Mail

Jul 22, 2026

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - The Globe and Mail

Jul 22, 2026

Robbins LLP Reminds WGS Investors of the Pending Class - GlobeNewswire

Jul 22, 2026

WGS Deadline Alert: Levi & Korsinsky Reminds GeneDx Holdings Corp. (WGS) Investors of Securities Class Action Deadline on August 3, 2026 - PR Newswire

Jul 22, 2026

Jul 21, 2026

GeneDx (WGS) Is Still Growing in Core Testing, but the Guidance Reset Changed the Story - AlphaStreet

Jul 21, 2026